Clinical MedicineUpdated Aug 20, 2026Version v1
Reviewed milestones, validation shifts, standards, datasets, and debates linked to public evidence.
Evidence from Blood indicates that Nonmyeloablative conditioning is well-tolerated with no severe procedure-related toxicity. This is tracked as a standard because it changes how Regenerative medicine and stem cell therapies is understood, validated, or applied.
Evidence from Journal of Cellular Physiology indicates that MSCs can be expanded in culture while maintaining multipotency. This is tracked as a clinical because it changes how Regenerative medicine and stem cell therapies is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.